Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia syndrome

Giulio Rossi, Paolo Spagnolo, Nicola Sverzellati, Lucia Longo, Agita Jukna, Gloria Montanari, Giada Vincenzi, Giuseppe Bogina, Renato Franco, Marcello Tiseo, Vincent Cottin, Thomas V. Colby

Research output: Contribution to journalArticle

Abstract

The term diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) may be used to describe a clinico-pathological syndrome, as well as an incidental finding on histological examination, although there are obvious differences between these two scenarios. According to the World Health Organization, the definition of DIPNECH is purely histological. However, DIPNECH encompasses symptomatic patients with airway disease, as well as asymptomatic patients with neuroendocrine cell hyperplasia associated with multiple tumourlets/carcinoid tumours. DIPNECH is also considered a pre-neoplastic lesion in the spectrum of pulmonary neuroendocrine tumours, because it is commonly found in patients with peripheral carcinoid tumours. In this review, we summarise clinical, physiological, radiological and histological features of DIPNECH and critically discuss recently proposed diagnostic criteria. In addition, we propose that the term "DIPNECH syndrome" be used to indicate a sufficiently distinct patient subgroup characterised by respiratory symptoms, airflow obstruction, mosaic attenuation with air trapping on chest imaging and constrictive obliterative bronchiolitis, often with nodular proliferation of neuroendocrine cells with/without tumourlets/carcinoid tumours on histology. Surgical lung biopsy is the diagnostic gold standard. However, in the appropriate clinical and radiological setting, transbronchial lung biopsy may also allow a confident diagnosis of DIPNECH syndrome.

Original languageEnglish
Pages (from-to)1829-1841
Number of pages13
JournalActa tuberculosea Scandinavica
Volume47
Issue number6
DOIs
Publication statusPublished - Jun 1 2016

Fingerprint

Neuroendocrine Cells
Hyperplasia
Lung
Carcinoid Tumor
Bronchiolitis Obliterans
Biopsy
Pulmonary Ventilation
Incidental Findings
Neuroendocrine Tumors
Histology
Thorax
Air

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Rossi, G., Spagnolo, P., Sverzellati, N., Longo, L., Jukna, A., Montanari, G., ... Colby, T. V. (2016). Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia syndrome. Acta tuberculosea Scandinavica, 47(6), 1829-1841. https://doi.org/10.1183/13993003.01954-2015

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia syndrome. / Rossi, Giulio; Spagnolo, Paolo; Sverzellati, Nicola; Longo, Lucia; Jukna, Agita; Montanari, Gloria; Vincenzi, Giada; Bogina, Giuseppe; Franco, Renato; Tiseo, Marcello; Cottin, Vincent; Colby, Thomas V.

In: Acta tuberculosea Scandinavica, Vol. 47, No. 6, 01.06.2016, p. 1829-1841.

Research output: Contribution to journalArticle

Rossi, G, Spagnolo, P, Sverzellati, N, Longo, L, Jukna, A, Montanari, G, Vincenzi, G, Bogina, G, Franco, R, Tiseo, M, Cottin, V & Colby, TV 2016, 'Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia syndrome', Acta tuberculosea Scandinavica, vol. 47, no. 6, pp. 1829-1841. https://doi.org/10.1183/13993003.01954-2015
Rossi G, Spagnolo P, Sverzellati N, Longo L, Jukna A, Montanari G et al. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia syndrome. Acta tuberculosea Scandinavica. 2016 Jun 1;47(6):1829-1841. https://doi.org/10.1183/13993003.01954-2015
Rossi, Giulio ; Spagnolo, Paolo ; Sverzellati, Nicola ; Longo, Lucia ; Jukna, Agita ; Montanari, Gloria ; Vincenzi, Giada ; Bogina, Giuseppe ; Franco, Renato ; Tiseo, Marcello ; Cottin, Vincent ; Colby, Thomas V. / Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia syndrome. In: Acta tuberculosea Scandinavica. 2016 ; Vol. 47, No. 6. pp. 1829-1841.
@article{a56f5ebe72f545a6b46493687dff71c7,
title = "Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia syndrome",
abstract = "The term diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) may be used to describe a clinico-pathological syndrome, as well as an incidental finding on histological examination, although there are obvious differences between these two scenarios. According to the World Health Organization, the definition of DIPNECH is purely histological. However, DIPNECH encompasses symptomatic patients with airway disease, as well as asymptomatic patients with neuroendocrine cell hyperplasia associated with multiple tumourlets/carcinoid tumours. DIPNECH is also considered a pre-neoplastic lesion in the spectrum of pulmonary neuroendocrine tumours, because it is commonly found in patients with peripheral carcinoid tumours. In this review, we summarise clinical, physiological, radiological and histological features of DIPNECH and critically discuss recently proposed diagnostic criteria. In addition, we propose that the term {"}DIPNECH syndrome{"} be used to indicate a sufficiently distinct patient subgroup characterised by respiratory symptoms, airflow obstruction, mosaic attenuation with air trapping on chest imaging and constrictive obliterative bronchiolitis, often with nodular proliferation of neuroendocrine cells with/without tumourlets/carcinoid tumours on histology. Surgical lung biopsy is the diagnostic gold standard. However, in the appropriate clinical and radiological setting, transbronchial lung biopsy may also allow a confident diagnosis of DIPNECH syndrome.",
author = "Giulio Rossi and Paolo Spagnolo and Nicola Sverzellati and Lucia Longo and Agita Jukna and Gloria Montanari and Giada Vincenzi and Giuseppe Bogina and Renato Franco and Marcello Tiseo and Vincent Cottin and Colby, {Thomas V.}",
year = "2016",
month = "6",
day = "1",
doi = "10.1183/13993003.01954-2015",
language = "English",
volume = "47",
pages = "1829--1841",
journal = "European Journal of Respiratory Diseases",
issn = "0903-1936",
publisher = "European Respiratory Society",
number = "6",

}

TY - JOUR

T1 - Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia syndrome

AU - Rossi, Giulio

AU - Spagnolo, Paolo

AU - Sverzellati, Nicola

AU - Longo, Lucia

AU - Jukna, Agita

AU - Montanari, Gloria

AU - Vincenzi, Giada

AU - Bogina, Giuseppe

AU - Franco, Renato

AU - Tiseo, Marcello

AU - Cottin, Vincent

AU - Colby, Thomas V.

PY - 2016/6/1

Y1 - 2016/6/1

N2 - The term diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) may be used to describe a clinico-pathological syndrome, as well as an incidental finding on histological examination, although there are obvious differences between these two scenarios. According to the World Health Organization, the definition of DIPNECH is purely histological. However, DIPNECH encompasses symptomatic patients with airway disease, as well as asymptomatic patients with neuroendocrine cell hyperplasia associated with multiple tumourlets/carcinoid tumours. DIPNECH is also considered a pre-neoplastic lesion in the spectrum of pulmonary neuroendocrine tumours, because it is commonly found in patients with peripheral carcinoid tumours. In this review, we summarise clinical, physiological, radiological and histological features of DIPNECH and critically discuss recently proposed diagnostic criteria. In addition, we propose that the term "DIPNECH syndrome" be used to indicate a sufficiently distinct patient subgroup characterised by respiratory symptoms, airflow obstruction, mosaic attenuation with air trapping on chest imaging and constrictive obliterative bronchiolitis, often with nodular proliferation of neuroendocrine cells with/without tumourlets/carcinoid tumours on histology. Surgical lung biopsy is the diagnostic gold standard. However, in the appropriate clinical and radiological setting, transbronchial lung biopsy may also allow a confident diagnosis of DIPNECH syndrome.

AB - The term diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) may be used to describe a clinico-pathological syndrome, as well as an incidental finding on histological examination, although there are obvious differences between these two scenarios. According to the World Health Organization, the definition of DIPNECH is purely histological. However, DIPNECH encompasses symptomatic patients with airway disease, as well as asymptomatic patients with neuroendocrine cell hyperplasia associated with multiple tumourlets/carcinoid tumours. DIPNECH is also considered a pre-neoplastic lesion in the spectrum of pulmonary neuroendocrine tumours, because it is commonly found in patients with peripheral carcinoid tumours. In this review, we summarise clinical, physiological, radiological and histological features of DIPNECH and critically discuss recently proposed diagnostic criteria. In addition, we propose that the term "DIPNECH syndrome" be used to indicate a sufficiently distinct patient subgroup characterised by respiratory symptoms, airflow obstruction, mosaic attenuation with air trapping on chest imaging and constrictive obliterative bronchiolitis, often with nodular proliferation of neuroendocrine cells with/without tumourlets/carcinoid tumours on histology. Surgical lung biopsy is the diagnostic gold standard. However, in the appropriate clinical and radiological setting, transbronchial lung biopsy may also allow a confident diagnosis of DIPNECH syndrome.

UR - http://www.scopus.com/inward/record.url?scp=84973495189&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84973495189&partnerID=8YFLogxK

U2 - 10.1183/13993003.01954-2015

DO - 10.1183/13993003.01954-2015

M3 - Article

VL - 47

SP - 1829

EP - 1841

JO - European Journal of Respiratory Diseases

JF - European Journal of Respiratory Diseases

SN - 0903-1936

IS - 6

ER -